DND Technologies, Inc. (DNDT)
New York City, NY, US
Headquartered in New York City, DND Technologies, Inc. was established in 1997. Operating as a holding company, DND Technologies specializes in the production and sale of diverse specialty balms. Beyond balms, the company is a key manufacturer and distributor of pharmaceutical goods. Its portfolio includes Bioassaygen Gel, formulated to diminish wrinkles and promote natural skin regeneration. The Bioassaygen Cosmetic Mask serves aesthetic enhancement purposes. Additionally, DND offers Bioassaygen Bio-Skin, an innovative skin replacement bandage, and Bioassaygen Delivery Gel, designed to accelerate natural skin renewal. These products reach consumers and businesses through a multi-channel distribution strategy, encompassing wholesale, retail outlets, and e-commerce platforms.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for DNDT
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
